Neuromuscular blocking agents and reversal agents

被引：0

作者：

Ahmad, Shahzaib ^{[1
]}

Handslip, Rhodri ^{[1
]}

机构：

[1] St Georges Univ Hosp NHS Trust, Intens Care Med, London, England

来源：

ANAESTHESIA AND INTENSIVE CARE MEDICINE | 2024年 / 25卷 / 09期

关键词：

Acetylcholine; aminosteroid; benzylisoquinolinium; neostigmine; neuromuscular blocking drugs; neuromuscular junction; succinylcholine; sugammadex;

D O I：

10.1016/j.mpaic.2024.07.001

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

The neuromuscular junction is a complex structure consisting of the muscle cell, the nerve terminal of a motor neuron and the synaptic cleft. It is the site of action for neuromuscular blocking drugs, which are a cornerstone of anaesthetic practice. These drugs can be divided into depolarizing and non-depolarizing drugs; the latter can be further subdivided into benzylisoquinolinium and aminosteroid compounds. Reversal agents are also discussed. The pharmacology of neuromuscular blocking drugs and reversal agents is discussed including mechanism of action, metabolism, factors influencing choice of drug as well as adverse effect profile.

引用

页码：595 / 599

页数：5

共 50 条

[11] Appropriate Use of Neuromuscular Blocking Agents and Reversal Drugs to Enhance Recovery Following Cardiac Surgery [J].

Gerlach, Rebecca M. ;

Chaney, Mark A. .

CURRENT ANESTHESIOLOGY REPORTS, 2020, 10 (03) :267-272

[12] Cucurbit[n]uril type hosts for the reversal of steroidal neuromuscular blocking agents [J].

Macartney, Donal H. .

FUTURE MEDICINAL CHEMISTRY, 2013, 5 (17) :2075-2089

[13] REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study) [J].

Greco, Massimiliano ;

Caruso, Pier Francesco ;

Angelotti, Giovanni ;

Aceto, Romina ;

Coppalini, Giacomo ;

Martinetti, Nicolo ;

Albini, Marco ;

Bash, Lori D. ;

Carvello, Michele ;

Piccioni, Federico ;

Monzani, Roberta ;

Montorsi, Marco ;

Cecconi, Maurizio .

JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)

[14] Adverse reactions to neuromuscular blocking agents [J].

Paul-Michel Mertes ;

Marie Claire Laxenaire .

Current Allergy and Asthma Reports, 2004, 4 :7-16

[15] Clinical pharmacology of neuromuscular blocking agents [J].

Fisher, DM .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (11) :S4-S9

[16] Neuromuscular blocking agents in paediatric anaesthesia [J].

Fisher, DM .

BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (01) :58-64

[17] Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review [J].

Hafeez, Khawaja Rashid ;

Tuteja, Arvind ;

Singh, Mandeep ;

Wong, David T. ;

Nagappa, Mahesh ;

Chung, Frances ;

Wong, Jean .

BMC ANESTHESIOLOGY, 2018, 18

[18] The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds [J].

Gonzalez-Estrada, Alexei ;

Carrillo-Martin, Ismael ;

Morgenstern-Kaplan, Dan ;

Garzon-Siatoya, W. Tatiana ;

Renew, J. Ross ;

Hernandez-Torres, Vivian ;

Volcheck, Gerald W. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (02) :466-+

[19] Neuromuscular Blocking Agents and Cancer: A Narrative Review [J].

Chen, Rui ;

Sun, Yan ;

Li, Yufan ;

Dou, Xiaoke ;

Dai, Maosha ;

Sun, Shujun ;

Lin, Yun .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023, 2023

[20] Neuromuscular blocking agents in the intensive care unit [J].

Rodriguez-Blanco, Jonathan ;

Rodriguez-Yanez, Tomas ;

Daniel Rodriguez-Blanco, Jesus ;

Jose Almanza-Hurtado, Amilkar ;

Cristina Martinez-Avila, Maria ;

Borre-Naranjo, Diana ;

Acuna Caballero, Maria Camila ;

Duenas-Castell, Carmelo .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (09)

← 1 2 3 4 5 →